Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

C Fagnoni

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Soins. Chirurgie (Paris, France : 1982)|February 1, 1995
[Postoperative pain]C Fagnoni, S Vanetti, P Oberlin
Journal Francais D'Ophtalmologie|December 11, 2012
[Galenic and analytic development of tacrolimus 0.06% eye drops]A-S Gauthier, B Rival, J Sahler, et al.
Journal Francais D'Ophtalmologie|August 1, 2022
Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathyM H Le Nguyen, M S Naoum, C Andre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2008
Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence studyL Chaigneau, B Royer, D Montange, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Soins. Chirurgie (Paris, France : 1982)|February 1, 1995
[Postoperative pain]C Fagnoni, S Vanetti, P Oberlin
Journal Francais D'Ophtalmologie|December 11, 2012
[Galenic and analytic development of tacrolimus 0.06% eye drops]A-S Gauthier, B Rival, J Sahler, et al.
Journal Francais D'Ophtalmologie|August 1, 2022
Physicochemical and microbiological stability of insulin eye drops in an artificial tear vehicle used in the treatment of refractory neurotrophic keratopathyM H Le Nguyen, M S Naoum, C Andre, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|October 28, 2008
Influence of capecitabine absorption on its metabolites pharmacokinetics: a bioequivalence studyL Chaigneau, B Royer, D Montange, et al.
Pageof 1